These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7480551)

  • 21. Effects of N-methyl-D-aspartate receptor antagonists on discriminative stimulus effects of naloxone in morphine-dependent rats using the Y-maze drug discrimination paradigm.
    Medvedev IO; Dravolina OA; Bespalov AY
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1260-8. PubMed ID: 9732387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.
    Schmidt-Mutter C; Pain L; Sandner G; Gobaille S; Maitre M
    Eur J Pharmacol; 1998 Jan; 342(1):21-7. PubMed ID: 9544788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do benzodiazepine receptors mediate the anticonflict action of pentobarbital?
    Mendelson WB; Davis T; Paul SM; Skolnick P
    Life Sci; 1983 May; 32(19):2241-6. PubMed ID: 6302426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines.
    Saitoh A; Sugiyama A; Yamada M; Inagaki M; Oka J; Nagase H; Yamada M
    Neuropharmacology; 2013 Apr; 67():485-93. PubMed ID: 23246531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiolytic-like effects of 4-phenyl-2-trichloromethyl-3H-1, 5-benzodiazepine hydrogen sulfate in mice.
    Rubin MA; Albach CA; Berlese DB; Bonacorso HG; Bittencourt SR; Queiroz CM; Maixner AE; Mello CF
    Braz J Med Biol Res; 2000 Sep; 33(9):1069-73. PubMed ID: 10973140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mammillary body is a potential site of antianxiety action of benzodiazepines.
    Kataoka Y; Shibata K; Gomita Y; Ueki S
    Brain Res; 1982 Jun; 241(2):374-7. PubMed ID: 6125244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats.
    Volke V; Soosaar A; Kõks S; Vasar E; Männistö PT
    Eur J Pharmacol; 1998 Jun; 351(3):287-90. PubMed ID: 9721019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential interactions of Ro 15-4513 with benzodiazepines, ethanol and pentobarbital.
    Deacon RM; Budhram P; Thomson TA; Gardner CR
    Eur J Pharmacol; 1990 May; 180(2-3):283-90. PubMed ID: 1973116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naloxone blocks the effects of chlordiazepoxide on acquisition but not performance of differential reinforcement of low rates of response (DRL).
    Tripp G; McNaughton N; Oei TP
    Psychopharmacology (Berl); 1987; 91(1):112-8. PubMed ID: 2881314
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pentobarbital-induced hyperactivity in mice: negligible role of opioid mechanisms.
    Vetulani J; Pavone F; Battaglia M; Sansone M
    Pharmacol Biochem Behav; 1989 Aug; 33(4):927-9. PubMed ID: 2616613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
    Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
    Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioral characterization of the novel GABAB receptor-positive modulator GS39783 (N,N'-dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine): anxiolytic-like activity without side effects associated with baclofen or benzodiazepines.
    Cryan JF; Kelly PH; Chaperon F; Gentsch C; Mombereau C; Lingenhoehl K; Froestl W; Bettler B; Kaupmann K; Spooren WP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):952-63. PubMed ID: 15113848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of tolerance to the anxiolytic effect of diazepam and pentobarbital following chronic administration in perinatally undernourished rats.
    Borghese CM; Córdoba NE; Laino CH; Orsingher OA; Rubio MC; Niselman V
    Brain Res Bull; 1998 Jun; 46(3):237-44. PubMed ID: 9667818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.
    Sugiyama A; Saitoh A; Iwai T; Takahashi K; Yamada M; Sasaki-Hamada S; Oka J; Inagaki M; Yamada M
    Neuropharmacology; 2012 Jun; 62(8):2489-98. PubMed ID: 22377384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuation of reperfusion hyperalgesia in the rat by systemic administration of benzodiazepines.
    Cartmell SM; Mitchell D
    Br J Pharmacol; 1993 Nov; 110(3):1067-72. PubMed ID: 8298795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    Singh L; Field MJ; Hughes J; Menzies R; Oles RJ; Vass CA; Woodruff GN
    Br J Pharmacol; 1991 Sep; 104(1):239-45. PubMed ID: 1686205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines.
    Kang W; Wilson SP; Wilson MA
    Neuropsychopharmacology; 2000 Jan; 22(1):77-88. PubMed ID: 10633493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.